Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Stereotactic Radiotherapy for Treating Brain Oligometastases - A Prospective Longitudinal Neurocognitive Study

NCT04805255 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT04805255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04805255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Stereotactic Radiotherapy for Treating Brain Oligometastases - A Prospective Longitudinal Neurocognitive Study
Lead sponsor
Chang Gung Memorial Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 25, 2021
Completion date
March 10, 2027
Enrollment
135 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult